On the arduous and tortuous path of new drug discovery, exuberant natural products (both extracts and isolated single molecules) may serve as the shortcut or key resources of new drug candidates. Understanding of the mechanism of action and the innovative technical application in natural products research will surely be helpful in accelerating the procedure [1] .
HepG2, and cervical cancer cells HeLa [9] . γ-Tocotrienol, an isoprenoid belonging to the vitamin E family, was found to induce the apoptosis of HeLa cells, accompanied by downregulation of Bcl-2, upregulation of Bax, and release of cytochrome c from mitochondria, as well as the activation of caspase-9, caspase-3, and subsequent poly (ADP-ribose) polymerase cleavage, indicating a mitochondria-mediated apoptosis mechanism [10] . Traditional Chinese medicine Chan Su is obtained from the skin and parotid venom glands of toads. Steroid arenobufagin was isolated from Chan Su and was found to promote apoptotic cell death in A549 cells through the activation of Noxa-related pathways, suggesting it to be a promising agent for patients with non-small cell lung cancer [11] .
Other different chemical-structure-related products also possessed specific anticancer effects. Elaiophylin, a 16-member macrodiolide antibiotic extracted from Streptomyces melanosporus, exhibited potent antiangiogenic activity in vitro and in vivo at nontoxic concentrations in angiogenesis assays as shown in the study by Lim et al. Elaiophylin could inhibit hypoxia-inducible factor-1α and vascular endothelial growth factor (VEGF) receptor 2, leading to the inhibition of VEGF-induced proliferation, migration, adhesion, invasion, and tube formation of human umbilical vein endothelial cells (HUVECs) [12] . Compound (E)-caffeic acid-9-O-β-D-xylpyranosyl-(1,2)-β-D-glucopyranosyl ester, a phenolic isolated and identified from Dryopteris fragrans (L.), showed potent anticancer effects on A549 cells, breast cancer cells MCF-7, and gastric cancer cells SGC7901 and HUVECs, among which MCF-7 was the most sensitive [13] .
Natural product extracts also shine in cancer treatment and are widely used, especially in Asia. In Seifaddinipour et al.'s study, ethyl acetate extracts from pistachio (Pistacia vera L.) hulls, abundant with phenolic and flavonoid compounds, showed potent apoptosis-inducing and angiogenesis inhibition effects on MCF-7 cells, human colon cancer HT-29, and HCT-116 cells [14] . Essential oils (a concentrated hydrophobic liquid containing volatile aroma compounds) from Origanum vulgare subsp hirtum, had a lower IC 50 in hepatocarcinoma HepG2 cells than in the healthy human renal cells HEK293, indicating its selectivity to be utilized as cancer therapeutic agents [15] . Combination of Prunus spinosa Trigno ecotype (PsT) drupe extract with a nutraceutical activator complex (NAC) made of amino acids, vitamins, and mineral salt blends, which was named PsT + NAC ® , showed anticancer activity in colon carcinoma cells HCT116 and SW480 cells via apoptosis-induction; by contrast, it did not alter normal cells [16] . Vernonia amygdalina Delile methanolic extracts exhibited significant growth-inhibitory effects on human androgen-independent prostate cancer cells PC-3 through the induction of cell growth arrest, DNA damage, apoptosis, and necrosis, demonstrating novel possibilities for developing prostate cancer therapies [17] . In Qiao et al.'s study, the polyyne-enriched extract from O. elatus (PEO) significantly improved body weight changes and reduced the tumor burden and tumor multiplicity in test mice compared with the untreated Apc Min/+ mice. Further study indicated that PEO could reduce the expression of β-catenin and cyclinD1 in both small intestine and colon tissues [18] . As shown in Moreno-Celis et al.'s work, tepary bean lectin fraction (TBLF) significantly decreased early tumorigenesis triggered by 1,2-dimethylhydrazine by 70% in rat models. TBLF exhibited antiproliferative and proapoptotic effects in the azoxy-methane/dextran sodium sulfate-induced in vivo model through decreasing the signal transduction pathway protein Akt in its activated form and increasing the activity of caspase-3 [19] . Finally, a review by Reddy et al. described the chemical compounds of Angelica gigas Nakai and their biosynthesis, efficient extraction and formulation methods, and underlying mechanisms for chronic diseases such as cervical cancer, prostate cancer, melanoma, bladder and colon cancer, lung cancer, and sarcoma were summarized, providing useful information for researchers in this area [20] .
Most natural products fail to enter clinical application due to poor pharmacokinetic profiles. Two studies related to structural modifications of natural products are included in this special issue. Gambogic acid, a xanthonoid derived from Garcinia, possessed poor aqueous solubility and cell permeability. DDO-6318, with a 1,2,3-triazole ring scaffold, was a synthetic analogue of gambogic acid guided by click chemistry. This new compound showed better drug properties as well as in vivo anticancer activity [21] . An analogue with better bioavailability modified based on curcumin (the principal curcuminoid of turmeric [Curcuma longa]), DK1, was found to exhibit cytotoxic effects on U-2OS and MG-63 osteosarcoma cell lines by inducing the expression of caspase-3, caspase-9, and Bax, activating apoptosis through a mitochondria-dependent signaling pathway [22] . These two research studies provide a novel strategy for further structural modification of natural products.
Several research studies were also conducted to overcome drug-resistant cancers in this special issue. Examples include compound 6 [5] and andrographolide [6] . 6-gingerol, 10-gingerol, 6-shogaol, and 10-shogaol, isolated from ginger, significantly inhibited the proliferation of docetaxel-resistant human prostate cancer cell line PC3R via downregulation of multidrug resistance-associated protein 1 and glutathione-S-transferase protein expression [23] . N-Butylidenephthalide, an active component of Radix Angelica Sinensis (danggui), showed potent inhibition and radiosensitization in human MDA-MB-231 and MCF-7 breast cancer cell lines [24] . These studies indicated that many natural products may work as sensitizing agents for MDR cancer treatment.
In conclusion, this special issue provides multiple research topics on the potential anticancer characteristics of natural products and some of their synthetic analogues. Many of them demonstrated certain MDR-overcoming effects in cancer cells that warrant further research. The insights of these studies will shed light on new drug discoveries and contribute to novel anticancer therapeutics.
